Search
Results: 2
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review.
BACKGROUND: Despite the increasing economic assessment of biomarker-guided therapies, no clear agreement exists whether existing methods are sufficient or whether different methods might produce different cost-effectiveness...
biomarker Cancer Companion biomarker Companion diagnostic cost-effectiveness economic evaluation health economics oncology Precision Medicine Systematic review targeted therapy Antineoplastic Combined Chemotherapy Protocols Biomarkers Tumor Cost-Benefit Analysis Humans Molecular Targeted Therapy Neoplasms Precision Medicine Prognosis ROC Curve Survival Rate
How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review
Abstract: Background: Despite the increasing economic assessment of biomarker-guided therapies, no clear agreement exists whether existing methods are sufficient or whether different methods might produce different...